tradingkey.logo

Bio Rad Laboratories Inc

BIO
查看詳細走勢圖
300.930USD
+1.070+0.36%
收盤 12/19, 16:00美東報價延遲15分鐘
8.12B總市值
虧損本益比TTM

Bio Rad Laboratories Inc

300.930
+1.070+0.36%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.36%

5天

-2.34%

1月

-0.88%

6月

+27.11%

今年開始到現在

-8.40%

1年

-8.10%

查看詳細走勢圖

TradingKey Bio Rad Laboratories Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Bio Rad Laboratories Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名39/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價355.00。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bio Rad Laboratories Inc評分

相關信息

行業排名
39 / 208
全市場排名
117 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 6 分析師
買入
評級
355.000
目標均價
+15.06%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bio Rad Laboratories Inc亮點

亮點風險
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
估值合理
公司最新PE估值-12.56,處於3年歷史合理位
機構減倉
最新機構持股20.58M股,環比減少0.02%
景順投資公司持倉
明星投資者景順投資公司持倉,最新持倉16.82K股

Bio Rad Laboratories Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bio Rad Laboratories Inc簡介

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
公司代碼BIO
公司Bio Rad Laboratories Inc
CEOSchwartz (Norman D)
網址https://www.bio-rad.com/

常見問題

Bio Rad Laboratories Inc(BIO)的當前股價是多少?

Bio Rad Laboratories Inc(BIO)的當前股價是 300.930。

Bio Rad Laboratories Inc 的股票代碼是什麼?

Bio Rad Laboratories Inc的股票代碼是BIO。

Bio Rad Laboratories Inc股票的52週最高點是多少?

Bio Rad Laboratories Inc股票的52週最高點是373.690。

Bio Rad Laboratories Inc股票的52週最低點是多少?

Bio Rad Laboratories Inc股票的52週最低點是211.430。

Bio Rad Laboratories Inc的市值是多少?

Bio Rad Laboratories Inc的市值是8.12B。

Bio Rad Laboratories Inc的淨利潤是多少?

Bio Rad Laboratories Inc的淨利潤為-1.84B。

現在Bio Rad Laboratories Inc(BIO)的股票是買入、持有還是賣出?

根據分析師評級,Bio Rad Laboratories Inc(BIO)的總體評級為買入,目標價格為355.000。

Bio Rad Laboratories Inc(BIO)股票的每股收益(EPS TTM)是多少

Bio Rad Laboratories Inc(BIO)股票的每股收益(EPS TTM)是-24.014。
KeyAI